Status:
ACTIVE_NOT_RECRUITING
Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen
Lead Sponsor:
Sohag University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Dose\_dense Capecitabine Schedule in colorectal cancers
Detailed Description
Dose\_dense Capecitabine schedule\[7 days on\_7days off\] in colorectal cancer in comparison with standerd regimen
Eligibility Criteria
Inclusion
- patients who diagnosed colorectal cancer Performance status ranging from 0 to 2 Both sexs
Exclusion
- pateints with other malignancy Pateints who have other comorbid diseas
Key Trial Info
Start Date :
September 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07215936
Start Date
September 25 2025
End Date
September 1 2028
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hospital
Sohag, Egypt